Table A2.
Screening Tests Recommended, Completed, and Evaluable
Test Type | Tests Recommended, No. | Tests Completed |
Tests Evaluable*
|
||
---|---|---|---|---|---|
No. | % | No. | % | ||
Complete blood count | 566 | 563 | 99.5 | 563 | 100.0 |
Blood urea nitrogen/creatinine | 305 | 301 | 98.7 | 301 | 100.0 |
Urinalysis for proteinuria | 935 | 933 | 99.8 | 933 | 100.0 |
Urinalysis for hematuria | 875 | 873 | 99.8 | 845 | 96.8 |
Liver function tests | 264 | 263 | 99.6 | 263 | 100.0 |
Potassium, phosphorus, magnesium | 83 | 83 | 100.0 | 83 | 100.0 |
Thyroid-stimulating hormone (baseline) | 124 | 119 | 96.0 | 119 | 100.0 |
Audiogram | 71 | 66 | 93.0 | 62 | 93.9 |
DEXA scan | 196 | 190 | 96.9 | 190 | 100.0 |
Ferritin | 96 | 96 | 100.0 | 96 | 100.0 |
Pulmonary function testing | 146 | 145 | 99.3 | 145 | 100.0 |
Chest x-ray | 150 | 149 | 99.3 | 149 | 100.0 |
ECG | 253 | 248 | 98.0 | 248 | 100.0 |
Echocardiogram | 542 | 539 | 99.4 | 533 | 98.9 |
Hepatitis B screening | 30 | 29 | 96.7 | 29 | 100.0 |
Hepatitis C screening | 141 | 137 | 97.2 | 137 | 100.0 |
HIV screening | 78 | 68 | 87.2 | 68 | 100.0 |
Follicle-stimulating hormone (females) | 73 | 61 | 83.6 | 61 | 100.0 |
Testosterone (males) | 65 | 61 | 93.8 | 61 | 100.0 |
Mammogram | 69 | 68 | 98.6 | 68 | 100.0 |
Total | 5,062 | 4,992 | 98.6 | 4,954 | 99.2 |
Abbreviation: DEXA, dual-energy x-ray absorptiometry.
Of the tests that were completed.